SOURCE_NAME_AID	Japan_Designated_Substances_Class_I_Old_AID_1
DATA_COLLECTION	Japan Designated Substances Class I Old
ASSAY_NAME	Japan's Class I Designated Chemical Substances (Old)
ASSAY_DESCRIPTION	Japan's Class I Designated Chemical Substances (Old) "Old" means chemicals before revision.  Class I chemicals are Persistent, Highly bioaccumulative. Has long-term toxicity for humans or long-term toxicity predator animals at higher trophic level.
ASSAY_URL	http://www.prtr.nite.go.jp/english/class1e.html
QC_STATUS	QUEUED
ASSAY_COMP_ID	1
ASSAY_COMP_NAME	Specific Class I Designated Chemical Substances
ASSAY_COMP_DESC	Specific Class I Designated Chemical Substances
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT
ASSAY_COMP_TYPE	Primary
ASSAY_NOTE	"Specific Class I Designated Chemical Substances" in this list is meant for those specified in Article 4 of Cabinet Order for Law Concerning Reporting ,etc .of Releases to the Environment of Specific Chemical Substances and Promoting Improvements in Their Management.
ASSAY_COMP_ID	2
ASSAY_COMP_NAME	Notes
ASSAY_COMP_DESC	Notes
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT
ASSAY_COMP_TYPE	Primary
ASSAY_NOTE
END
SOURCE_NAME_AID	Japan_Designated_Substances_Class_I_New_AID_1
DATA_COLLECTION	Japan Designated Substances Class I New
ASSAY_NAME	Japan's Class I Designated Chemical Substances (New)
ASSAY_DESCRIPTION	Japan's Class I Designated Chemical Substances (New) "New" means chemicals after revision.  Class I chemicals are Persistent, Highly bioaccumulative. Has long-term toxicity for humans or long-term toxicity predator animals at higher trophic level.
ASSAY_URL	http://www.prtr.nite.go.jp/english/class1e_new.html
QC_STATUS	QUEUED
ASSAY_COMP_ID	1
ASSAY_COMP_NAME	Specific Class I Designated Chemical Substances
ASSAY_COMP_DESC	Specific Class I Designated Chemical Substances
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT
ASSAY_COMP_TYPE	Primary
ASSAY_NOTE	"Specific Class I Designated Chemical Substances" in this list is meant for those specified in Article 4 of Cabinet Order for Law Concerning Reporting ,etc .of Releases to the Environment of Specific Chemical Substances and Promoting Improvements in Their Management.
ASSAY_COMP_ID	2
ASSAY_COMP_NAME	Notes
ASSAY_COMP_DESC	Notes
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT
ASSAY_COMP_TYPE	Primary
ASSAY_NOTE
END
SOURCE_NAME_AID	Japan_Designated_Substances_Class_II_Old_AID_1
DATA_COLLECTION	Japan Designated Substances Class II Old
ASSAY_NAME	Japan's Class II Designated Chemical Substances (Old)
ASSAY_DESCRIPTION	Japan's Class II Designated Chemical Substances (Old) "Old" means chemicals before revision.  Class II chemicals have long-term toxicity for humans or flora and fauna in the human living environment. Has risk.
ASSAY_URL	http://www.prtr.nite.go.jp/english/class2e.html
QC_STATUS	QUEUED
ASSAY_COMP_ID	1
ASSAY_COMP_NAME	Notes
ASSAY_COMP_DESC	Notes
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT
ASSAY_COMP_TYPE	Primary
ASSAY_NOTE
END
SOURCE_NAME_AID	Japan_Designated_Substances_Class_II_New_AID_1
DATA_COLLECTION	Japan Designated Substances Class II New
ASSAY_NAME	Japan's Class II Designated Chemical Substances (New)
ASSAY_DESCRIPTION	Japan's Class II Designated Chemical Substances (New) "New" means chemicals after revision.  Class II chemicals have long-term toxicity for humans or flora and fauna in the human living environment. Has risk.
ASSAY_URL	http://www.prtr.nite.go.jp/english/class2e_new.html
QC_STATUS	QUEUED
ASSAY_COMP_ID	1
ASSAY_COMP_NAME	URL
ASSAY_COMP_DESC	URL
ASSAY_COMP_VALUE_TYPE	URL
ASSAY_COMP_UNIT
ASSAY_COMP_TYPE	Annotation
ASSAY_NOTE
END
SOURCE_NAME_AID	Japan_Risk_Assessments_AID_1
DATA_COLLECTION	Japan Risk Assessments
ASSAY_NAME	Japan's Summary of Initial Risk Assessments
ASSAY_DESCRIPTION	Japan's Summary of Risk Assessments for 150 substances - In Japan, a project entitled "Risk Assessment and Development of Methods for the Risk Assessment of Chemical Substances," funded by the New Energy and Industrial Technology Development Organization (NEDO), was started in 2001. Through this project, risk assessment methods for chemical substances in the environment were developed, and the series, "Initial Risk  Assessment Reports for Chemical Substances" was published. This series of reports covers 150 substances. The reports were created by the National Institute of Technology and Evaluation (NITE) and the Chemicals Evaluation and Research Institute, Japan (CERI).
ASSAY_URL	http://www.safe.nite.go.jp/english/risk/initial_risk.html
QC_STATUS	QUEUED
ASSAY_COMP_ID	1
ASSAY_COMP_NAME	URLs
ASSAY_COMP_DESC	Chemical-specoific URLs
ASSAY_COMP_VALUE_TYPE	URL
ASSAY_COMP_UNIT
ASSAY_COMP_TYPE	Annotation
ASSAY_NOTE
END
SOURCE_NAME_AID	Japan_PFAS_JECS_Pilot_2020_AID_1
DATA_COLLECTION	Japan PFAS JECS Pilot 2020
ASSAY_NAME	PFAS analysis of PFAS in serum samples (JECS Pilot Study)
ASSAY_DESCRIPTION	Japan NIES analysis of serum samples from Pilot Study of the Japan Environment and Children's Study (JECS)
ASSAY_URL	https://www.sciencedirect.com/science/article/pii/S0021967320301205
ASSAY_NOTE	Source: Poly- and perfluoroalkyl substances in maternal serum: Method development and application in Pilot Study of the Japan Environment and Children’s Study; Journal of Chromatography A. Volume 1618, 10 May 2020, 460933
ASSAY_NOTE	Data from Table 7 PFAS concentrations in human serum samples from the JECS Pilot Study (n = 339).
ASSAY_NOTE	method development: Protein precipitation, automatic SPE pre-treatment and column-switching LC-MS/MS were used and optimised in this study. 
ASSAY_NOTE	analysis of the levels of 28 PFAS in 339 maternal serum samples from Pilot Study of the Japan Environment and Children's Study.
ASSAY_NOTE	PFBA, PFPA, PFHxA, perfluorotetradecanoic acid (PFTeDA), PFHxDA, PFODA, perfluorodecane sulphonic acid (PFDS), EtFOSA-A, MeFOSA-M, EtFOSA-M, 4:2 FTS, 6:2 FTS, 8:2 FTS and diSAmPAP were below the LCMRLs in all samples
QC_STATUS	QUEUED
ASSAY_COMP_ID	1
ASSAY_COMP_NAME	Acronym
ASSAY_COMP_DESC	Substance Acronym
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	2
ASSAY_COMP_NAME	Min
ASSAY_COMP_DESC	Minimum Concentration
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	3
ASSAY_COMP_NAME	Median
ASSAY_COMP_DESC	Median Concentration
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	4
ASSAY_COMP_NAME	75th percentile
ASSAY_COMP_DESC	Concentration, 75th percentile
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	5
ASSAY_COMP_NAME	Max
ASSAY_COMP_DESC	Maximum Concentration
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	6
ASSAY_COMP_NAME	Detection
ASSAY_COMP_DESC	Number of Detections
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	7
ASSAY_COMP_NAME	Detection
ASSAY_COMP_DESC	% Detected
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	%
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	8
ASSAY_COMP_NAME	% l-PFAS
ASSAY_COMP_DESC	% linear-PFAS, Mean (SD)
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	%
ASSAY_COMP_TYPE	Primary
END
SOURCE_NAME_AID	Japan_PFAS_Maternal_Cord_2003_AID_3
DATA_COLLECTION	Japan PFAS Maternal Cord 2003
ASSAY_NAME	PFAS in maternal and cord serum in Japan 2003
ASSAY_DESCRIPTION	 PFAS in maternal and cord serum in Hokkaido, Japan 2003
ASSAY_URL	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1247483/
ASSAY_NOTE	Source: Perfluorooctane Sulfonate (PFOS) and Related Perfluorinated Compounds in Human Maternal and Cord Blood Samples: Assessment of PFOS Exposure in a Susceptible Population; Koichi Inoue, et al.; Environ Health Perspect  v.112(11); 2004 Aug
ASSAY_NOTE	Data from Table 2 Concentrations (ng/mL) of FOC congeners (PFOS, PFOA, and PFOSA) in maternal and cord blood samples (n = 15).
ASSAY_NOTE	We recruited subjects between February and July 2003 at Sapporo Toho Hospitals in Hokkaido, Japan
ASSAY_NOTE	FOCs in 15 pairs of maternal and cord blood samples. Pregnant women 17–37 years of age were enrolled as subjects.
ASSAY_NOTE	Blood was sampled from pregnant women between gestation weeks 38 and 41 
QC_STATUS	QUEUED
ASSAY_COMP_ID	1
ASSAY_COMP_NAME	Sample
ASSAY_COMP_DESC	Sample
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	2
ASSAY_COMP_NAME	Acronym
ASSAY_COMP_DESC	Substance Acronym
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	3
ASSAY_COMP_NAME
ASSAY_COMP_DESC	Participant 1
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	4
ASSAY_COMP_NAME	2
ASSAY_COMP_DESC	Participant 2
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	5
ASSAY_COMP_NAME	3
ASSAY_COMP_DESC	Participant 3
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	6
ASSAY_COMP_NAME	4
ASSAY_COMP_DESC	Participant 4
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	7
ASSAY_COMP_NAME	5
ASSAY_COMP_DESC	Participant 5
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	8
ASSAY_COMP_NAME	6
ASSAY_COMP_DESC	Participant 6
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	9
ASSAY_COMP_NAME	7
ASSAY_COMP_DESC	Participant 7
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	10
ASSAY_COMP_NAME	8
ASSAY_COMP_DESC	Participant 8
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	11
ASSAY_COMP_NAME	9
ASSAY_COMP_DESC	Participant 9
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	12
ASSAY_COMP_NAME	10
ASSAY_COMP_DESC	Participan10
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	13
ASSAY_COMP_NAME	11
ASSAY_COMP_DESC	Participant 11
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	14
ASSAY_COMP_NAME	12
ASSAY_COMP_DESC	Participant 12
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	15
ASSAY_COMP_NAME	13
ASSAY_COMP_DESC	Participant 13
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	16
ASSAY_COMP_NAME	14
ASSAY_COMP_DESC	Participant 14
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	17
ASSAY_COMP_NAME	15
ASSAY_COMP_DESC	Participant 16
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	18
ASSAY_COMP_NAME	LOD
ASSAY_COMP_DESC	LOD
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	19
ASSAY_COMP_NAME	Population city
ASSAY_COMP_DESC	Population city
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT
ASSAY_COMP_TYPE	Primary
END
SOURCE_NAME_AID	Japan_PFAS_Hokkaido_Plasma_2003-2012_AID_1
DATA_COLLECTION	Japan PFAS Hokkaido Plasma 2003-2012
ASSAY_NAME	PFAS in maternal plasma in Japanese Hokkaido Study (2003-2012)
ASSAY_DESCRIPTION	 PFAS in maternal plasma in Japanese Hokkaido Study (2003-2012)
ASSAY_URL	https://www.sciencedirect.com/science/article/pii/S0160412020319346?via%3Dihub
ASSAY_NOTE	Source: Ait Bamai Y, Goudarzi H, Araki A, Okada E, Kashino I, Miyashita C, Kishi R. 2020. Effect of prenatal exposure to per- and polyfluoroalkyl substances on childhood allergies and common infectious diseases in children up to age 7 years: The Hokkaido study on environment and children's health. Environ Int. 2020 Oct;143:105979.
ASSAY_NOTE	Data from Table 2. Distribution of maternal plasma PFAS levels (ng/mL).
ASSAY_NOTE	This study is a part of the Hokkaido study on environment and children's health (The Hokkaido Study)
ASSAY_NOTE	we included 2689 children who had completed maternal prenatal PFAS measurements and questionnaires at 7 years of age
ASSAY_NOTE	Briefly, of 20,926 children enrolled from February 2003 to March 2012, 20,787 had available data for analysis.
QC_STATUS	QUEUED
ASSAY_COMP_ID	1
ASSAY_COMP_NAME	Acronym
ASSAY_COMP_DESC	Substance Acronym
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	2
ASSAY_COMP_NAME	MDL
ASSAY_COMP_DESC	method of detection limit.
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	3
ASSAY_COMP_NAME	>MDL
ASSAY_COMP_DESC	greater than MDL
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	%
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	4
ASSAY_COMP_NAME	Min
ASSAY_COMP_DESC	Minimum concentration
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	5
ASSAY_COMP_NAME	25th
ASSAY_COMP_DESC	25th percentile concentration
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	6
ASSAY_COMP_NAME	50th
ASSAY_COMP_DESC	50th percentile concentration
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	7
ASSAY_COMP_NAME	75th
ASSAY_COMP_DESC	75th percentile concentration
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	8
ASSAY_COMP_NAME	max
ASSAY_COMP_DESC	maximum concentration
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT	ng/mL
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	9
ASSAY_COMP_NAME	Notes
ASSAY_COMP_DESC	Notes
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT
ASSAY_COMP_TYPE	Primary
ASSAY_COMP_ID	10
ASSAY_COMP_NAME	Population city
ASSAY_COMP_DESC	Population city
ASSAY_COMP_VALUE_TYPE	TEXT
ASSAY_COMP_UNIT
ASSAY_COMP_TYPE	Primary
END
